Association of Levels of Physical Activity With Risk of Parkinson Disease A Systematic Review and Meta-analysis

JAMA Network Open

Volumn 1, Issue 5, 2018, Pages

  Fang, Xuexian ^a   Han, Dan ^a   Cheng, Qi ^a   Zhang, Pan ^a   Zhao, Chunhui ^c   Min, Junxia ^a   Wang, Fudi ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c STATE KEY LABORATORY OF INDUSTRIAL CONTROL TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; COMPLICATION; EXERCISE; FEMALE; HUMAN; MALE; META ANALYSIS; MIDDLE AGED; PARKINSON DISEASE; PHYSIOLOGY; RISK FACTOR;

AGED; EXERCISE; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; RISK FACTORS;

EID: 85062812731     PISSN: None     EISSN: 25743805     Source Type: Journal    
DOI: 10.1001/jamanetworkopen.2018.2421     Document Type: Article

References (33)

1. Nussbaum RL, Ellis CE. Alzheimer’s disease and Parkinson’s disease. N Engl J Med. 2003;348(14):1356-1364. doi:10.1056/NEJM2003ra020003
2. Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J. Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol. 2011;26(suppl 1):S1-S58. doi:10.1007/s10654-011-9581-6
3. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the “common” neurologic disorders? Neurology. 2007;68(5):326-337. doi:10.1212/01.wnl.0000252807.38124.a3
4. Savica R, Grossardt BR, Bower JH, Ahlskog JE, Rocca WA. Time trends in the incidence of Parkinson disease. JAMA Neurol. 2016;73(8):981-989. doi:10.1001/jamaneurol.2016.0947
5. Zhang ZX, Roman GC, Hong Z, et al. Parkinson’s disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet. 2005;365(9459):595-597. doi:10.1016/S0140-6736(05)70801-1
6. Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257-1272. doi:10.1016/S1474-4422(16)30230-7
7. Garcia-Ruiz PJ, Espay AJ. Parkinson disease: an evolutionary perspective. Front Neurol. 2017;8:157. doi:10. 3389/fneur.2017.00157
8. Pandey A, Garg S, Khunger M, et al. Dose-response relationship between physical activity and risk of heart failure: a meta-analysis. Circulation. 2015;132(19):1786-1794. doi:10.1161/CIRCULATIONAHA.115.015853
9. Kyu HH, Bachman VF, Alexander LT, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ. 2016;354:i3857. doi:10.1136/bmj.i3857
10. Smith AD, Crippa A, Woodcock J, Brage S. Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies. Diabetologia. 2016;59(12):2527-2545. doi: 10.1007/s00125-016-4079-0
11. LaHue SC, Comella CL, Tanner CM. The best medicine? the influence of physical activity and inactivity on Parkinson’s disease. Mov Disord. 2016;31(10):1444-1454. doi:10.1002/mds.26728
12. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15): 2008-2012. doi:10.1001/jama.283.15.2008
13. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301-1309. doi:10.1093/oxfordjournals.aje.a116237
14. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 2006;6(1):40-57. https://www.stata-journal.com/article.html?article=st0096. Accessed August 31, 2018.
15. Fang X, Wang K, Han D, et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med. 2016;14(1):210. doi:10.1186/s12916-016-0742-z
16. Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80(15):1198-1202. doi:10.1093/jnci/80.15.1198
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327 (7414):557-560. doi:10.1136/bmj.327.7414.557
18. Chen H, Zhang SM, Schwarzschild MA, Hernán MA, Ascherio A. Physical activity and the risk of Parkinson disease. Neurology. 2005;64(4):664-669. doi:10.1212/01.WNL.0000151960.28687.93
19. Logroscino G, Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and risk of Parkinson’s disease: a prospective cohort study. J Neurol Neurosurg Psychiatry. 2006;77(12):1318-1322. doi:10.1136/jnnp.2006.097170
20. Sääksjärvi K, Knekt P, Männistö S, et al. Reduced risk of Parkinson’s disease associated with lower body mass index and heavy leisure-time physical activity. Eur J Epidemiol. 2014;29(4):285-292. doi:10.1007/s10654-014-9887-2
21. Sasco AJ, Paffenbarger RS Jr, Gendre I, Wing AL. The role of physical exercise in the occurrence of Parkinson’s disease. Arch Neurol. 1992;49(4):360-365. doi:10.1001/archneur.1992.00530280040020
22. Thacker EL, Chen H, Patel AV, et al. Recreational physical activity and risk of Parkinson’s disease. Mov Disord. 2008;23(1):69-74. doi:10.1002/mds.21772
23. Xu Q, Park Y, Huang X, et al. Physical activities and future risk of Parkinson disease. Neurology. 2010;75(4): 341-348. doi:10.1212/WNL.0b013e3181ea1597
24. Yang F, Trolle Lagerros Y, Bellocco R, et al. Physical activity and risk of Parkinson’s disease in the Swedish National March Cohort. Brain. 2015;138(Pt 2):269-275. doi:10.1093/brain/awu323
25. Tanaka K, Quadros AC Jr, Santos RF, Stella F, Gobbi LT, Gobbi S. Benefits of physical exercise on executive functions in older people with Parkinson’s disease. Brain Cogn. 2009;69(2):435-441. doi:10.1016/j.bandc.2008. 09.008
26. Schenkman M, Moore CG, Kohrt WM, et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol. 2018;75(2):219-226. doi:10.1001/jamaneurol.2017.3517
27. Paillard T, Rolland Y, de Souto Barreto P. Protective effects of physical exercise in Alzheimer’s disease and Parkinson’s disease: a narrative review. J Clin Neurol. 2015;11(3):212-219. doi:10.3988/jcn.2015.11.3.212
28. Zoladz JA, Pilc A, Majerczak J, Grandys M, Zapart-Bukowska J, Duda K. Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. J Physiol Pharmacol. 2008;59(suppl 7): 119-132.
29. Scalzo P, Kümmer A, Bretas TL, Cardoso F, Teixeira AL. Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson’s disease. J Neurol. 2010;257(4):540-545. doi:10.1007/s00415-009-5357-2
30. Ouchi Y, Kanno T, Okada H, et al. Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson’s disease. Brain. 2001;124(Pt 4):784-792. doi:10.1093/brain/124.4.784
31. Tillerson JL, Cohen AD, Caudle WM, Zigmond MJ, Schallert T, Miller GW. Forced nonuse in unilateral parkinsonian rats exacerbates injury. J Neurosci. 2002;22(15):6790-6799. doi:10.1523/JNEUROSCI.22-15-06790.2002
32. Tillerson JL, Caudle WM, Reverón ME, Miller GW. Exercise induces behavioral recovery and attenuates neurochemical deficits in rodent models of Parkinson’s disease. Neuroscience. 2003;119(3):899-911. doi:10.1016/ S0306-4522(03)00096-4
33. Bramer WM, Giustini D, Kramer BM. Comparing the coverage, recall, and precision of searches for 120 systematic reviews in Embase, MEDLINE, and Google Scholar: a prospective study. Syst Rev. 2016;5:39. doi:10. 1186/s13643-016-0215-7